FDA — authorised 22 April 1975
- Application: NDA017618
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: BRICANYL
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Bricanyl on 22 April 1975
Yes. FDA authorised it on 22 April 1975; FDA authorised it on 19 March 1985.
SANOFI AVENTIS US holds the US marketing authorisation.